Autres langues Bliss GVS Pharma Limited

Actions

BLISSGVS

INE416D01022

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:48 08/05/2024			Varia. 5j.	Varia. 1 janv.
112 ^INR	-0,40%		-9,46%	-10,11%

02/05	Bliss GVS Pharma Limited publie ses résultats pour l'exercice clos le 31 mars 2024	CI
02/05	Bliss GVS Pharma Limited annonce ses résultats pour le quatrième trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02/05
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	02/05
Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	02/05
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	01/11
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited	07/09/23
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao	01/08/23
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01/08/23
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023	19/07/23
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit	15/06/23
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	11/05/23
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	11/05/23
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	11/05/23
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable	10/04/23
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India	20/03/23
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	24/01/23
Bliss GVS Pharma Names New CFO	30/12/22
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer	30/12/22
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	07/11/22
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	03/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bliss GVS Pharma Limited

Actions

BLISSGVS

INE416D01022

Autres langues

Filtres